Home | Help | Feedback | Subscriptions | Archive | Search | Latest Articles

This Article Full Text Full Text (PDF, 4084K) PDF+supp data (4837K) PPT slides of all figures Supplemental Material Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via CrossRef Google Scholar Articles by Brien, J. D. Articles by Nikolich-Zugich, J. PubMed PubMed Citation Articles by Brien, J. D. Articles by Nikolich-Zugich, J. Social Bookmarking                            What's this?

James D. Brien^1,2,3, Jennifer L. Uhrlaub^1,2,4,5, Alec Hirsch^1,2, Clayton A. Wiley⁶, and Janko Nikolich-ugich^1,2,4,5

¹ Vaccine and Gene Therapy Institute and ² Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006
³ Department of Microbiology, Washington University, St. Louis, MO 63110
⁴ Department of Immunobiology and ⁵ Arizona Center on Aging, University of Arizona College of Medicine, Tucson, AZ, 85724
⁶ Department of Pathology, University of Pittsburgh College of Medicine, Pittsburgh, PA 15213

CORRESPONDENCE Janko Nikolich-ugich: nikolich{at}email.arizona.edu

West Nile virus (WNV) infection causes a life-threatening meningoencephalitis that becomes increasingly more prevalent over the age of 50 and is 40–50x more prevalent in people over the age of 70, compared with adults under the age of 40. In a mouse model of age-related vulnerability to WNV, we demonstrate that death correlates with increased viral titers in the brain and that this loss of virus control with age was the result of defects in the CD4 and CD8 T cell response against WNV. Specific age-related defects in T cell responses against dominant WNV epitopes were detected at the level of cytokine and lytic granule production, each of which are essential for resistance against WNV, and in the ability to generate multifunctional anti-WNV effector T cells, which are believed to be critical for robust antiviral immunity. In contrast, at the peak of the response, old and adult T cells exhibited superimposable peptide sensitivity. Most importantly, although the adult CD4 or CD8 T cells readily protected immunodeficient mice upon adoptive transfer, old T cells of either subset were unable to provide WNV-specific protection. Consistent with a profound qualitative and quantitative defect in T cell immunity, old brains contained at least 12x fewer total effector CD8 T cells compared with adult mice at the peak of brain infection. These findings identify potential targets for immunomodulation and treatment to combat lethal WNV infection in the elderly.

Abbreviations used: GzB, granzyme B; IFNAR, IFN-β receptor; MST, mean survival time; WNV, West Nile virus.

© 2009 Brien et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Home | Help | Feedback | Subscriptions | Archive | Search